The Candiroos (Leon Gussow, Steve Aks & Tim Erickson) lay down the SMACC on nebulised naloxone, opioid-induced hyperalgesia & Irukandji Syndrome.
CICM SAQ 2012.2 Q8
November 21, 2012 by Leave a Comment
Features of a randomised trial on a therapeutic intervention that would lead you to change your practice.
Emergency Medicine Update November 2012
November 21, 2012 by Leave a Comment
Here is the November 2012 edition of EMU. You can subscribe to EMU directly via email by sending a message to: jbleibmd AT yahoo.com Also, remember to check out previous editions of EMU on LITFL here.
Ben Goldacre on Bad Pharma
September 29, 2012 by 3 Comments
Ben Goldacre speaks at TEDMED about publication bias, the cancer eating at the heart of evidence-based medicine,
Lifestyle modification and multiple sclerosis
February 27, 2012 by 23 Comments
Changing the paradigm of progressive deterioration with multiple sclerosis. An Australian longitudinal cohort study reports remarkable improvements with lifestyle change
CICM SAQ 2010.1 Q21
January 27, 2012 by Leave a Comment
Factors causing medication errors in ICU adn how to minimise them.
R&R in the FASTLANE
November 9, 2011 by 24 Comments
R&R in the FASTLANE is an exciting new weekly resource that allows highly respected trustworthy emergency physicians, intensivists and related critical care specialists working in varied settings around the world tell us what they think is worth reading.
CICM SAQ 2011.2 Q23
October 21, 2011 by Leave a Comment
Questions In the context of statistical analysis of randomised controlled trials, explain the following terms: a) Risk ratio b) Number needed to treat c) P-value d) Confidence intervals Answers a) Risk ratio Answer and interpretation A risk ratio is simply a ratio of risk, for example, [risk of mortality in the intervention group] / [risk [...]
